These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37935817)

  • 1. Radioresistance or/and radiosensitivity of head and neck squamous cell carcinoma: biological angle.
    Li CX; Gong ZC; Zhang WN; Zhang Y; Zhao HR
    Oral Maxillofac Surg; 2024 Jun; 28(2):547-555. PubMed ID: 37935817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A radiobiological perspective on radioresistance or/and radiosensitivity of head and neck squamous cell carcinoma.
    Li CX; Tan XR; Wei W; Li MQ; Zhang WN; Gong ZC; Zhang Y; Zhao HR
    Rep Pract Oncol Radiother; 2023; 28(6):809-822. PubMed ID: 38515813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MitoTam induces ferroptosis and increases radiosensitivity in head and neck cancer cells.
    Reinema FV; Hudson N; Adema GJ; Peeters WJM; Neuzil J; Stursa J; Werner L; Sweep FCGJ; Bussink J; Span PN
    Radiother Oncol; 2024 Nov; 200():110503. PubMed ID: 39186982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of radioresistance in head and neck squamous cell carcinomas.
    Avril D; Foy JP; Bouaoud J; Grégoire V; Saintigny P
    Int J Radiat Biol; 2023; 99(4):583-593. PubMed ID: 35930497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of radiosensitivity in head and neck squamous cell carcinoma.
    Li G; Jiang Y; Li G; Qiao Q
    Radiother Oncol; 2021 Jun; 159():126-135. PubMed ID: 33775714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
    Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
    J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
    Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
    Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming radioresistance in head and neck squamous cell carcinoma.
    Yamamoto VN; Thylur DS; Bauschard M; Schmale I; Sinha UK
    Oral Oncol; 2016 Dec; 63():44-51. PubMed ID: 27938999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications.
    Perri F; Pacelli R; Della Vittoria Scarpati G; Cella L; Giuliano M; Caponigro F; Pepe S
    Head Neck; 2015 May; 37(5):763-70. PubMed ID: 24995469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
    Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
    BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NFE2L2 Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells.
    Guan L; Nambiar DK; Cao H; Viswanathan V; Kwok S; Hui AB; Hou Y; Hildebrand R; von Eyben R; Holmes BJ; Zhao J; Kong CS; Wamsley N; Zhang W; Major MB; Seol SW; Sunwoo JB; Hayes DN; Diehn M; Le QT
    Cancer Res; 2023 Mar; 83(6):861-874. PubMed ID: 36652552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma.
    Benaiges E; Ceperuelo-Mallafré V; Guaita S; Maymó-Masip E; Madeira A; Gómez D; Hernández V; Vilaseca I; Merma C; León X; Terra X; Vendrell J; Avilés-Jurado FX; Fernández-Veledo S
    Head Neck; 2024 Jul; 46(7):1752-1765. PubMed ID: 38305029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines.
    Todorovic V; Prevc A; Zakelj MN; Savarin M; Brozic A; Groselj B; Strojan P; Cemazar M; Sersa G
    Radiat Oncol; 2019 Nov; 14(1):214. PubMed ID: 31775835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cGAS Regulates the Radioresistance of Human Head and Neck Squamous Cell Carcinoma Cells.
    Nyui T; Yoshino H; Nunota T; Sato Y; Tsuruga E
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.
    Grünow J; Rong C; Hischmann J; Zaoui K; Flechtenmacher C; Weber KJ; Plinkert P; Hess J
    J Exp Clin Cancer Res; 2017 Feb; 36(1):25. PubMed ID: 28166815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
    Kurth I; Hein L; Mäbert K; Peitzsch C; Koi L; Cojoc M; Kunz-Schughart L; Baumann M; Dubrovska A
    Oncotarget; 2015 Oct; 6(33):34494-509. PubMed ID: 26460734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles and gene association networks.
    Michna A; Schötz U; Selmansberger M; Zitzelsberger H; Lauber K; Unger K; Hess J
    Radiat Oncol; 2016 Jul; 11():94. PubMed ID: 27455841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M2 macrophages reduce the radiosensitivity of head and neck cancer by releasing HB‑EGF.
    Fu E; Liu T; Yu S; Chen X; Song L; Lou H; Ma F; Zhang S; Hussain S; Guo J; Sun J; Yu P; Mao X; Wei L
    Oncol Rep; 2020 Aug; 44(2):698-710. PubMed ID: 32627036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mevalonate pathway activity as a determinant of radiation sensitivity in head and neck cancer.
    Ricco N; Flor A; Wolfgeher D; Efimova EV; Ramamurthy A; Appelbe OK; Brinkman J; Truman AW; Spiotto MT; Kron SJ
    Mol Oncol; 2019 Sep; 13(9):1927-1943. PubMed ID: 31225926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.